Insight and analysis of top stories from our award winning magazine "Bloomberg Businessweek".
Shoe designer and creative Salehe Bembury takes us on a journey from his childhood growing up in Manhattan, to an invaluable degree in industrial design, to working with some of the biggest names in fashion...before breaking off to make his own name. We see how Bembury is able to walk the line of business convention while taking his art to new heights, turning ordinary items into extraordinary footwear. Follow along as he lays out the blueprint for his career, and takes us all the way from his first sketch to his thriving personal brand, Spunge.
UK Workers Miss Out on Europe’s Shift to Fewer Hours on the Job
China Stocks Hope, Cheap Singapore Flats: Saturday Asia Briefing
Ukraine Economy Contracts Less Than Expected Despite Attacks
Canada Suffers Minor Job Losses, Snapping Eight-Month Streak
Fed Seen Ending Its 15-Month Hiking Campaign in Economist Survey
PGA Golfers Are Now Told to Love LIV After Forgoing Its Millions
Brad Setser on the Massive Shifts Underway in World Trade
OpenAI’s CEO Calls on China to Help Shape AI Safety Guidelines
Tesla’s Record Run Drives Nearly $200 Billion Jump in Value
Nordic Capital Pursues Temenos as Other Suitors Drop
Starmer Sacrifices Key Proposal to Protect His Path to Victory
Four Children Lost in Colombian Jungle After Plane Crash Are Alive
Why Billionaires Are Circling Debt-Laden French Grocer Casino
US Housing Market Is Missing 320,000 Affordable Homes
Trump Suit Against Niece Over NY Times Story Advances: Judge
Two of Paul Newman’s Daytona Rolexes Sell for More Than $1 Million
Smoky Orange Haze Amplifies Focus on Ventilation
Hedge Funds Meet Their #MeToo Moment
The Next Presidency Hinges on Trump's Court Case
The Netflix Effect Chills Foreign Content Creators
Payrolls, Prices, Productivity and Profits Hold the Answer to the Puzzling US Economy
Will Argentina Ditch the Peso for the Dollar?
Sunak Urged to Publish UK Report on Abuse of LGBTQ Soldiers
Dimon Sought for Fresh Deposition in JPMorgan Epstein Suit
After Lobbying Crush, Biden Set to Boost Biodiesel in Nation’s Fuel
What East Coast Cities Can Learn About Wildfire Policies From the West
NYC Pays Over $300 a Night for Budget Hotel Rooms for Migrants
Connecticut May Ban Collection Tactic Used in Cash-Advance Loans
Deep Drought Punishes Latin American Clean Water Pioneer
Robinhood Removes 3 Crypto Tokens Following Regulatory Crackdown
Coinbase Suit May Finally Send Crypto Debate to US Supreme Court
A New Crypto Banking System Arises Under the Shadow of a Regulatory Crackdown
Pfizer Inc. is seeking to add Express Scripts Inc. to the list of U.S. pharmacy benefits managers that won’t dispense generic Lipitor after the world’s best-selling drug loses patent protection this month.
Lipitor had $10.7 billion in sales last year, about half in the U.S. Deals made with companies such as insurer Coventry Health Care Inc. may help Pfizer retain as much as 40 percent of users through May, said Paul Bisaro, chief executive officer at Watson Pharmaceuticals Inc. Watson is producing a generic version approved by New York-based Pfizer.